These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38044105)

  • 21. Effects of newly synthetized isoquinoline derivatives on rat uterine contractility and ROCK II activity.
    Domokos D; Fülöp F; Falkay G; Gáspár R
    Bioorg Med Chem Lett; 2018 Feb; 28(3):466-469. PubMed ID: 29269216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Higher Ca
    Mochalov SV; Tarasova NV; Kudryashova TV; Gaynullina DK; Kalenchuk VU; Borovik AS; Vorotnikov AV; Tarasova OS; Schubert R
    Acta Physiol (Oxf); 2018 Jul; 223(3):e13044. PubMed ID: 29383848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of Rho/Rho-kinase system in regulation of vascular smooth muscle contraction in tachycardia-induced heart failure.
    Hisaoka T; Yano M; Ohkusa T; Suetsugu M; Ono K; Kohno M; Yamada J; Kobayashi S; Kohno M; Matsuzaki M
    Cardiovasc Res; 2001 Feb; 49(2):319-29. PubMed ID: 11164842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The vasodilatory effect of the antidiabetic drug linagliptin via inhibition of Rho-associated protein kinase in aortic smooth muscle.
    Seo MS; Li H; An JR; Jang JH; Jung HS; Kim T; Kook S; Jung WK; Choi IW; Na SH; Park WS
    Life Sci; 2019 Feb; 219():1-10. PubMed ID: 30620894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rho kinase inhibitor fasudil mitigates high-cholesterol diet-induced hypercholesterolemia and vascular damage.
    Abdali NT; Yaseen AH; Said E; Ibrahim TM
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Apr; 390(4):409-422. PubMed ID: 28101628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of arterial stiffness in the onset of Takotsubo cardiomyopathy observed with noradrenaline administration and intracranial blood injection in rabbits.
    Takahashi M; Miyazaki C; Xin C; Sato S; Shimizu K; Chiba T; Tsukuma H; Komatsu T; Aimoto M; Nagasawa Y; Takahara A; Shirai K
    Heart Vessels; 2023 May; 38(5):740-748. PubMed ID: 36629930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological profile of hydroxy fasudil as a selective rho kinase inhibitor on ischemic brain damage.
    Satoh S; Utsunomiya T; Tsurui K; Kobayashi T; Ikegaki I; Sasaki Y; Asano T
    Life Sci; 2001 Aug; 69(12):1441-53. PubMed ID: 11531167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of ripasudil (K-115), a Rho kinase inhibitor, on activation of human conjunctival fibroblasts.
    Futakuchi A; Inoue T; Fujimoto T; Inoue-Mochita M; Kawai M; Tanihara H
    Exp Eye Res; 2016 Aug; 149():107-115. PubMed ID: 27394186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Rho Kinase Inhibitor Ripasudil (K-115) on Isolated Porcine Retinal Arterioles.
    Kamiya T; Omae T; Nakabayashi S; Takahashi K; Tanner A; Yoshida A
    J Ocul Pharmacol Ther; 2021 Mar; 37(2):104-111. PubMed ID: 33351704
    [No Abstract]   [Full Text] [Related]  

  • 30. Vasodilator actions of HA1077 in vitro and in vivo putatively mediated by the inhibition of protein kinase.
    Asano T; Suzuki T; Tsuchiya M; Satoh S; Ikegaki I; Shibuya M; Suzuki Y; Hidaka H
    Br J Pharmacol; 1989 Dec; 98(4):1091-100. PubMed ID: 2611484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term inhibition of Rho kinase with fasudil attenuates high flow induced pulmonary artery remodeling in rats.
    Li F; Xia W; Li A; Zhao C; Sun R
    Pharmacol Res; 2007 Jan; 55(1):64-71. PubMed ID: 17127075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of fasudil, a Rho-associated protein kinase inhibitor, on optic nerve head blood flow in rabbits.
    Sugiyama T; Shibata M; Kajiura S; Okuno T; Tonari M; Oku H; Ikeda T
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):64-9. PubMed ID: 20720232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rho-kinase inhibition attenuates calcium-induced contraction in β-escin but not Triton X-100 permeabilized rabbit femoral artery.
    Clelland LJ; Browne BM; Alvarez SM; Miner AS; Ratz PH
    J Muscle Res Cell Motil; 2011 Sep; 32(2):77-88. PubMed ID: 21706258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles of rho-associated kinase and oxidative stress in the pathogenesis of aortic stiffness.
    Noma K; Goto C; Nishioka K; Jitsuiki D; Umemura T; Ueda K; Kimura M; Nakagawa K; Oshima T; Chayama K; Yoshizumi M; Liao JK; Higashi Y
    J Am Coll Cardiol; 2007 Feb; 49(6):698-705. PubMed ID: 17291936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between serum uric acid, aortic, carotid and femoral stiffness among adults aged 40-75 years without and with type 2 diabetes mellitus: The Maastricht Study.
    Wijnands JM; Boonen A; van Sloten TT; Schram MT; Sep SJ; Koster A; van der Kallen CJ; Henry RM; Dagnelie PC; Stehouwer CD; van der Linden S; Arts IC
    J Hypertens; 2015 Aug; 33(8):1642-50. PubMed ID: 26136069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
    Chen XY; Dun JN; Miao QF; Zhang YJ
    Pharmacology; 2009; 83(2):67-79. PubMed ID: 19052484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fasudil, a Rho-kinase inhibitor, inhibits leukocyte adhesion in inflamed large blood vessels in vivo.
    Slotta JE; Braun OO; Menger MD; Thorlacius H
    Inflamm Res; 2006 Sep; 55(9):364-7. PubMed ID: 17122957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sevoflurane inhibits angiotensin II-induced Rho kinase-mediated contraction of vascular smooth muscle from spontaneously hypertensive rat.
    Uematsu N; Ogawa K; Tokinaga Y; Tange K; Hatano Y
    J Anesth; 2011 Jun; 25(3):398-404. PubMed ID: 21409351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of pulmonary vasodilator responses to SB-772077-B [4-(7-((3-amino-1-pyrrolidinyl)carbonyl)-1-ethyl-1H-imidazo(4,5-c)pyridin-2-yl)-1,2,5-oxadiazol-3-amine], a novel aminofurazan-based Rho kinase inhibitor.
    Dhaliwal JS; Badejo AM; Casey DB; Murthy SN; Kadowitz PJ
    J Pharmacol Exp Ther; 2009 Jul; 330(1):334-41. PubMed ID: 19369577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of cholesterol lowering on stiffness of aortic and femoral arterial walls in rabbits on a high fat diet.
    Xue L; Xu WH; Xu JZ; Zhang T; Bi HY; Shen BZ
    Chin Med J (Engl); 2009 Jun; 122(12):1444-8. PubMed ID: 19567169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.